VANCOUVER, May 26, 2020 /CNW/ - Geyser Brands Inc.
(TSX-V: GYSR)("Geyser Brands" or the "Company") is pleased
to announce the receipt of their Natural Product Number (NPN) from
Health Canada for their hemp-based topical Eczema (Psoriasis)
cream. Through the issuance of the NPN, products that carry an NPN
have been assessed by Health Canada and found to be safe, effective
and of high quality under their recommended conditions of use. The
new product has proved to be very effective in the treatment of
both Psoriasis & Eczema.
Geyser Brands' Solace subsidiary is authorized to market and
sell their Eczema cream as a natural health product through
the Apothecary Naturals and SToND
Naturals line of products.
Solace will also be offering a version of this product
through the brand Apothecary Labs in the
regulated Cannabis market. Apothecary Labs will be using the
same base product and adding CBD & THC.
According to a report Aug 2019 by
Grand View Research, Inc., the global atopic dermatitis drugs
market size is expected to reach USD
6.41 billion by 2022.
With distribution through traditional retailers and
direct-to-consumer, products are expected to hit shelves in June,
2020. Regulated cannabis versions are expected to be
available at government licensed dispensaries by August 2020.
The Solace subsidiary carries the Apothecary line of brands
including:
- Apothecary Naturals: 100% all-natural, organic,
hemp-based products for everything from skin care to pain
relief.
Website: https://www.apothecarynaturals.ca/
- SToND Naturals: Luxury 100% all natural, organic
plant-based products for skin care.
- Website: https://www.stondnaturals.com
- Website: https://www.apothecarylabs.com/
"Receiving our NPN supports our vision to develop and build
brands based on trust and credibility in an emerging but heavily
regulated industry. Our continued focus on natural, healthy
ingredients along with world-class formulations has been recognized
with this NPN and we look forward to rolling these out in
Canada as a first step in building
a global presence", stated Geyser Brands Chairman, Brad Kersch.
About Geyser Brands
Geyser Brands Inc. develops consumer product brands in the
health and wellness sector that use hemp and CBD as a value-added
ingredient. These involve next-generation formulas that focus on
the mix of cannabinoids for specific conditions such as insomnia,
anxiety and pain.
Proprietary delivery technologies include all natural
nano-technology, slow-release mechanisms and non-molecule degrading
baking processes. In anticipation of coming edibles legislation,
and with its Health Canada approved Licensed Production Facility,
Geyser Brands has 15,000 square feet in two GMP facilities in
Vancouver, BC.
For more information, visit Geyser Brands' website at
www.geyserbrands.com.
On Behalf of the Board of Directors
"Andreas Thatcher"
____________________________________
Andreas Thatcher
Director and CEO
info@geyserbrands.com
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
This news release contains forward‐looking
statements and forward‐looking information within the
meaning of applicable securities laws. These statements relate to
future events or future performance. All statements other than
statements of historical fact may be forward‐looking
statements or information. Forward‐looking statements
and information are often, but not always, identified by the use of
words such as "appear", "seek", "anticipate", "plan", "continue",
"estimate", "approximate", "expect", "may", "will", "project",
"predict", "potential", "targeting", "intend", "could", "might",
"should", "believe", "would" and similar expressions.
Forward-looking statements and information are provided for
the purpose of providing information about the current expectations
and plans of management of the Company relating to the future.
Readers are cautioned that reliance on such statements and
information may not be appropriate for other purposes, such as
making investment decisions. Since forward‐looking
statements and information address future events and conditions, by
their very nature they involve inherent risks and uncertainties.
Actual results could differ materially from those currently
anticipated due to a number of factors and risks. These include,
but are not limited to, the risks associated with the marijuana
industry in general such as operational risks in growing;
competition; incorrect assessment of the value and potential
benefits of various transactions; ability to access sufficient
capital from internal and external sources; failure to obtain
required regulatory and other approvals and changes in legislation,
including but not limited to tax laws and government regulations.
Accordingly, readers should not place undue reliance on the
forward‐looking statements, timelines and information
contained in this news release. Readers are cautioned that the
foregoing list of factors is not exhaustive. Additional
information relating to Geyser is available
at www.sedar.com.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
SOURCE Geyser Brands Inc.